Psychiatry & Neurology Doctors in Mattoon, IL Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Annmarie S Mcdonagh, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1005 Health Center Dr Ste 102, Mattoon, IL 61938 Phone: 217-258-4042    Fax: 217-258-4053

Dr. Kathleen A. Hecksel, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1005 Health Center Dr Ste 101, Mattoon, IL 61938 Phone: 217-238-4866    Fax: 217-238-4868

John Lauer, MD Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr Ste 107, Mattoon, IL 61938 Phone: 217-258-4096    Fax: 217-238-5485

Thomas L Minogue, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 200 Lerna Road South, Mattoon, IL 61938 Phone: 217-258-5900    Fax: 217-258-5904

Fatima Alao, M.D. Medicare: Accepting Medicare Assignments Practice Location: 1000 Health Center Dr Ste 107, Mattoon, IL 61938 Phone: 217-258-4096    Fax: 217-238-5485

Dr. Elbert C. Lee, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1005 Health Center Drive, Suite 102, Mattoon, IL 61938 Phone: 217-258-4042    Fax: 217-258-4053

Johnathon Prentice Yost, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1005 Health Center Dr Ste 102, Mattoon, IL 61938 Phone: 218-258-4042    Fax: 217-258-4042

News Archive

GenVec reports net loss of $1.7 million for second quarter 2014

GenVec, Inc. today reported financial results for the three-month and six-month periods ended June 30, 2014. For the three-month period ended June 30, 2014, the company reported a net loss of $1.7 million or $0.10 per share on revenues of $0.1 million as compared to a net loss of $3.1 million or $0.24 per share on revenues of $0.7 million in the same period in the prior year.

Endocyte prices initial public offering

Endocyte, Inc., a biopharmaceutical company developing targeted small molecule drug conjugates, announced today the pricing of its initial public offering of 12,500,000 shares of its common stock.

Certain genes could lead to stress fracture injuries

In a paper published in The Official Journal of the International Purine Club University of Liverpool researchers have successfully identified how certain genes can contribute towards a person's susceptibility to stress fracture injuries. This research provides a platform for further research into providing a personalised health approach to this common sports injury.

Bioneutral's broad spectrum antimicrobial eradicates the H1N1 swine flu virus

BioNeutral Group, Inc. ("BioNeutral") (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia, demonstrated that Ygiene® antimicrobial diluted 1 to 10 with water can totally eradicated the H1N1 Swine Flu virus in 59 seconds on an unclean, soiled surface.

Autism spectrum disorder: Earlier diagnosis, better treatment

The age at which a child with autism is diagnosed is related to the particular suite of behavioral symptoms he or she exhibits, new research from the University of Wisconsin-Madison shows.

Read more Medical News

› Verified 9 days ago